/**
 * Novalyte AI Journal — Long-form article content registry
 *
 * This file contains the structured editorial content for the Novalyte AI
 * Journal. Articles are educational in nature and do not constitute medical
 * advice. All articles are clearly marked as educational content; medical
 * disclaimers are rendered separately in the article view.
 *
 * References are to well-known public-health and professional-society sources
 * (FDA, NIH/NIDDK, CDC, Endocrine Society, AUA, etc.) and are labeled
 * "for general reference" — readers should consult the original sources for
 * current clinical guidance.
 *
 * Authors and reviewers shown are members of the Novalyte editorial team.
 * Where a "medical reviewer" is null, the article is an operational or
 * industry piece that does not require clinical review.
 */

export type ArticleBlock =
  | { type: "heading"; level: 2 | 3; text: string; id: string }
  | { type: "paragraph"; text: string }
  | { type: "list"; items: string[]; ordered?: boolean }
  | { type: "callout"; tone: "info" | "warning" | "tip"; text: string }
  | { type: "table"; headers: string[]; rows: string[][] };

export type ArticleContent = {
  slug: string;
  title: string;
  excerpt: string;
  category: string;
  tags: string[];
  author: { name: string; role: string; bio: string };
  medicalReviewer: { name: string; role: string } | null;
  publishedAt: string;
  updatedAt: string;
  readingTime: number;
  heroImage: string;
  heroImageAlt: string;
  tableOfContents: { id: string; title: string }[];
  body: ArticleBlock[];
  references: { label: string; source: string }[];
  faqs: { question: string; answer: string }[];
  relatedTreatment: string | null;
};

// Build table of contents from level-2 headings
function tocFromBlocks(blocks: ArticleBlock[]): { id: string; title: string }[] {
  return blocks
    .filter((b): b is { type: "heading"; level: 2; text: string; id: string } => b.type === "heading" && b.level === 2)
    .map((b) => ({ id: b.id, title: b.text }));
}

// ────────────────────────────────────────────────────────────────────────────
// Article 1: TRT overview (Testosterone) — 1,500+ words
// ────────────────────────────────────────────────────────────────────────────
const trtBlocks: ArticleBlock[] = [
  { type: "paragraph", text: "Testosterone replacement therapy (TRT) is a clinically supervised treatment used when a licensed healthcare provider confirms that a man's testosterone levels are persistently below the normal range and that the symptoms he is experiencing are consistent with that deficiency. This article explains how TRT is typically evaluated, what the treatment pathway looks like, what monitoring is involved, and what questions are useful to ask a provider. It is an educational overview, not medical advice, and no two clinical situations are identical." },

  { type: "callout", tone: "info", text: "Direct answer: TRT is not a wellness shortcut or a performance enhancer. It is a prescribed medical therapy for confirmed low testosterone (hypogonadism) that requires laboratory diagnosis, an individualized treatment plan, and ongoing clinical monitoring. The decision to start, continue, or stop TRT is made between a patient and a licensed clinician." },

  { type: "heading", level: 2, id: "what-is-testosterone-replacement-therapy", text: "What is testosterone replacement therapy?" },
  { type: "paragraph", text: "Testosterone is the primary male sex hormone, produced mostly in the testes under the control of signals from the brain (the hypothalamus and pituitary gland). It supports muscle mass, bone density, red-blood-cell production, libido, mood regulation, and certain cognitive functions. When production falls persistently below the reference range — and symptoms align — clinicians may diagnose hypogonadism." },
  { type: "paragraph", text: "TRT restores testosterone through a prescribed delivery method: injections, transdermal gels or patches, subcutaneous pellets, buccal tablets, or, in some regions, oral formulations. The route chosen depends on patient preference, clinical suitability, cost, and local availability. None of these routes is universally 'best' — they differ in absorption kinetics, convenience, and side-effect profile." },

  { type: "heading", level: 2, id: "how-low-testosterone-is-evaluated", text: "How is low testosterone evaluated?" },
  { type: "paragraph", text: "Diagnosis does not rest on a single lab value. The Endocrine Society and the American Urological Association (AUA) both emphasize a structured evaluation that combines symptoms, repeated laboratory testing, and exclusion of reversible causes." },
  { type: "list", ordered: true, items: [
    "Symptom assessment — fatigue, low libido, erectile changes, depressed mood, reduced muscle mass, or poor concentration.",
    "Morning total testosterone — drawn typically between 7 a.m. and 11 a.m., when levels peak. A single low value is never enough; guideline-driven evaluation requires at least two separate mornings confirming low levels.",
    "Free or calculated testosterone — when total testosterone is borderline or when conditions like obesity alter sex-hormone-binding globulin (SHBG).",
    "Pituitary hormones — LH and FSH help distinguish primary (testicular) from secondary (pituitary/hypothalamic) causes.",
    "Prolactin and other labs — to rule out secondary causes such as a pituitary lesion when clinically indicated.",
    "Review of medications and lifestyle factors — opioids, glucocorticoids, severe obesity, sleep apnea, and chronic illness can all suppress testosterone and may resolve without hormones.",
  ]},
  { type: "callout", tone: "warning", text: "Self-prescribing testosterone, buying it from non-pharmacy sources, or using it for athletic enhancement is unsafe and is not TRT. Misuse can cause infertility, cardiovascular strain, suppression of natural hormone production, and other harms — and is outside any legitimate clinical pathway." },

  { type: "heading", level: 2, id: "what-to-expect-during-treatment", text: "What to expect during treatment" },
  { type: "paragraph", text: "If TRT is clinically appropriate and a patient consents, the provider selects a delivery method, sets a starting dose, and schedules follow-up labs — typically at 3 to 6 months initially, then at regular intervals once stable. Symptom changes are gradual; some men notice improvements in energy or mood within weeks, while changes in body composition may take months. Symptom response varies and is not guaranteed." },
  { type: "paragraph", text: "Adjustments to dose or dosing interval are normal. The goal is to keep total testosterone within the physiologic range — not above it. 'More is better' is not the clinical framework; sustained, monitored, in-range levels are." },

  { type: "heading", level: 3, id: "common-delivery-methods-compared", text: "Common delivery methods compared" },
  { type: "table", headers: ["Method", "Typical dosing", "Practical notes"], rows: [
    ["Intramuscular / subcutaneous injection", "Weekly to every 1–2 weeks (longer-acting esters vary)", "Predictable dosing; peaks and troughs require monitoring; self-administration possible after training."],
    ["Transdermal gel", "Daily application to clean, dry skin", "Steady levels; risk of partner/child transfer if skin contact occurs before dried."],
    ["Transdermal patch", "Daily", "Steady levels; some users experience skin irritation."],
    ["Subcutaneous pellets", "Implanted every 3–6 months", "Long-acting; minor in-office procedure; cannot self-remove if side effects occur."],
    ["Buccal tablet", "Twice daily, applied to gumline", "Steady levels; local gum irritation reported in some users."],
  ]},
  { type: "paragraph", text: "Routes and formulations available differ by country, regulation, and clinic. A clinician will recommend based on the individual's full clinical picture, not on a generic preference." },

  { type: "heading", level: 2, id: "monitoring-and-safety", text: "Monitoring and safety" },
  { type: "paragraph", text: "Guideline-consistent monitoring during TRT typically includes total testosterone levels (drawn at the right time relative to dosing), hematocrit or hemoglobin (because testosterone can stimulate red-blood-cell production), and prostate-related screening consistent with age-appropriate guidelines. Bone density, lipid profile, and cardiovascular risk factors may also be tracked depending on the patient." },
  { type: "list", items: [
    "Hematocrit — elevated levels may require dose adjustment, therapeutic phlebotomy, or暂停 to reduce blood viscosity.",
    "Prostate health — digital rectal exam and PSA screening per age-appropriate guidelines; new or worsening urinary symptoms should be reported.",
    "Cardiovascular risk factors — blood pressure, lipid profile, and overall risk profile are reviewed alongside TRT.",
    "Fertility — TRT suppresses sperm production; men planning to father children should discuss alternatives such as hCG or referral to a reproductive specialist.",
  ]},
  { type: "callout", tone: "tip", text: "Tip: Bring your lab results, a list of current medications, and a symptom diary to every visit. Tracking energy, mood, sleep, and exercise across several weeks gives your provider meaningful signal beyond a single point-in-time lab." },

  { type: "heading", level: 2, id: "questions-to-ask-your-provider", text: "Questions to ask your provider" },
  { type: "list", items: [
    "What do my lab results show, and were they repeated on a separate morning?",
    "Are there reversible causes (weight, sleep apnea, medications, stress) we should address first?",
    "What are the realistic benefits and the specific risks for my health profile?",
    "Which delivery method do you recommend for me, and why?",
    "How often will labs be drawn, and what thresholds would prompt a change?",
    "What is the plan if I want to stop TRT in the future?",
    "How does TRT affect fertility if I plan to have children?",
  ]},

  { type: "heading", level: 2, id: "lifestyle-factors-that-support-outcomes", text: "Lifestyle factors that support outcomes" },
  { type: "paragraph", text: "TRT is not a substitute for the foundational habits that influence hormone health. Sleep, regular resistance and aerobic exercise, weight management, alcohol moderation, stress reduction, and management of conditions like type 2 diabetes and obstructive sleep apnea all affect testosterone and overall wellbeing. In some men, addressing obesity and sleep apnea can raise testosterone substantially without pharmacologic therapy." },
  { type: "paragraph", text: "A provider may recommend working with a dietitian, exercise professional, behavioral health clinician, or sleep specialist as part of a broader plan. TRT, when appropriate, sits inside this broader plan — not in place of it." },

  { type: "heading", level: 2, id: "what-trt-is-not", text: "What TRT is not" },
  { type: "paragraph", text: "TRT is not prescribed for men with normal testosterone levels who want improved athletic performance or cosmetic changes. Using testosterone for those purposes — outside a confirmed diagnosis and clinical relationship — is misuse, carries real risks, and is not what this article describes. TRT is also not a treatment for aging itself: age-related decline in testosterone is common, but only warrants treatment when levels fall below the clinical threshold and symptoms are present." },

  { type: "callout", tone: "warning", text: "Novalyte AI is a technology platform. It does not diagnose low testosterone, prescribe TRT, or operate a pharmacy. Any clinical decision described here is made by a licensed healthcare professional in the context of an individual clinical relationship." },
];

// ────────────────────────────────────────────────────────────────────────────
// Article 2: GLP-1 medical weight loss (Weight Management) — 1,500+ words
// ────────────────────────────────────────────────────────────────────────────
const glp1Blocks: ArticleBlock[] = [
  { type: "paragraph", text: "GLP-1 receptor agonists have become a frequently discussed option within medically supervised weight loss programs. This article explains how GLP-1 medications work, who tends to be evaluated for them, what monitoring is involved, and how they fit alongside nutrition, activity, and behavioral support. It is educational, not medical advice, and does not recommend or prescribe any specific medication." },

  { type: "callout", tone: "info", text: "Direct answer: GLP-1 medications are prescription drugs used alongside lifestyle change in eligible patients under clinical supervision. They are not standalone solutions, not appropriate for everyone, and require ongoing monitoring. A licensed clinician decides whether they are appropriate based on individual health factors." },

  { type: "heading", level: 2, id: "what-glp-1-medications-are", text: "What GLP-1 medications are" },
  { type: "paragraph", text: "GLP-1 (glucagon-like peptide-1) receptor agonists mimic a hormone the gut naturally releases after eating. They act on receptors that affect insulin secretion, glucagon regulation, gastric emptying, and appetite signaling in the brain. Some GLP-1 agonists are approved for type 2 diabetes management; others are approved for chronic weight management in eligible patients; some are approved for both indications." },
  { type: "paragraph", text: "Distinguishing between these regulatory approvals matters. A medication approved for type 2 diabetes is not automatically appropriate for weight management in someone without diabetes, and the specific indication, dose, and supervision differ. Generic categories — 'weight loss injections' — conceal clinically meaningful differences between medications." },

  { type: "heading", level: 2, id: "how-glp-1-medications-work", text: "How GLP-1 medications work" },
  { type: "list", ordered: true, items: [
    "Appetite regulation — GLP-1 receptors in the brain reduce hunger and increase satiety, often leading to reduced caloric intake.",
    "Gastric emptying — they slow the rate at which food leaves the stomach, contributing to fullness.",
    "Glucose metabolism — they enhance glucose-dependent insulin secretion and suppress glucagon, which is why some are used in type 2 diabetes.",
  ]},
  { type: "paragraph", text: "These mechanisms explain why GLP-1 medications are not 'quick fixes' — they support behavioral change by changing hunger and satiety signaling, not by directly burning fat. Without nutrition and behavior support, weight regain after discontinuation is well documented." },

  { type: "heading", level: 2, id: "who-might-be-evaluated", text: "Who might be evaluated" },
  { type: "paragraph", text: "Eligibility for a GLP-1 medication is determined by a clinician based on BMI, weight-related conditions (such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea), prior weight-loss attempts, contraindications, and the specific medication's approved indication. The criteria below reflect the general structure of regulatory indications, but the final decision rests with the prescribing provider." },
  { type: "table", headers: ["Indication area", "Typical framework (general)"], rows: [
    ["Type 2 diabetes", "Some GLP-1 agonists approved as adjunct to diet/exercise for glycemic control."],
    ["Chronic weight management", "Generally considered in adults with BMI ≥30, or BMI ≥27 with a weight-related condition, when other approaches have not been sufficient."],
    ["Adolescents", "A subset of medications has specific adolescent indications; pediatric use requires specialist evaluation."],
  ]},
  { type: "callout", tone: "warning", text: "Contraindications and cautions matter. Personal or family history of certain endocrine tumors (notably medullary thyroid carcinoma or MEN2), pancreatitis history, severe gastroparesis, and pregnancy or breastfeeding are among the factors that can make GLP-1 therapy inappropriate. A full history is essential." },

  { type: "heading", level: 2, id: "what-monitoring-involves", text: "What monitoring involves" },
  { type: "paragraph", text: "When a GLP-1 medication is prescribed, follow-up typically includes tolerability assessment, weight tracking, side-effect review, and laboratory monitoring as clinically indicated. Dose escalation follows a titration schedule that aims to balance efficacy with gastrointestinal tolerability; abrupt dose increases are not standard practice." },
  { type: "list", items: [
    "Symptom review — nausea, reflux, constipation, diarrhea, and appetite changes are common early in treatment.",
    "Weight and body composition — weight is tracked, but body composition and metabolic markers give a fuller picture than weight alone.",
    "Metabolic labs — blood glucose, HbA1c (when relevant), lipids, and kidney function may be monitored.",
    "Review of co-medications — insulin or sulfonylureas may require dose adjustment to avoid hypoglycemia.",
    "Discontinuation planning — a plan for tapering or transitioning should be discussed before starting.",
  ]},

  { type: "heading", level: 2, id: "lifestyle-factors-alongside-medication", text: "Lifestyle factors alongside medication" },
  { type: "paragraph", text: "Guidelines from professional societies — including the American Gastroenterological Association and obesity medicine specialists — consistently frame medication as an adjunct to lifestyle intervention, not a replacement for it. The behavioral foundation that supports long-term outcomes includes:" },
  { type: "list", ordered: true, items: [
    "Structured nutrition guidance — typically emphasizing protein adequacy, fiber intake, and an eating pattern sustainable over years rather than weeks.",
    "Physical activity — both resistance training (to preserve lean mass during weight loss) and aerobic activity (for cardiovascular and metabolic benefit).",
    "Sleep and stress — inadequate sleep and chronic stress both influence appetite-regulating hormones and adherence.",
    "Behavioral support — regular check-ins, accountability structures, and addressing emotional or binge eating patterns.",
  ]},
  { type: "callout", tone: "tip", text: "Tip: Protein intake and resistance training become especially important during weight loss, because losing weight involves both fat and lean tissue. Preserving muscle during weight loss supports long-term metabolic health." },

  { type: "heading", level: 2, id: "what-to-discuss-with-a-clinician", text: "What to discuss with a clinician" },
  { type: "list", items: [
    "Whether a GLP-1 medication is appropriate given my full medical history — including thyroid, pancreatic, and gallbladder history.",
    "What realistic, guideline-consistent outcomes look like for someone in my situation.",
    "What side effects are most common and how they are typically managed.",
    "How long treatment might last and what the plan is for discontinuation.",
    "What the total cost will be over months to years, including medication, monitoring, and lifestyle support.",
    "What alternatives exist — including structured lifestyle programs, other medication classes, or referral for procedural intervention.",
  ]},

  { type: "heading", level: 2, id: "avoiding-misuse-and-counterfeits", text: "Avoiding misuse and counterfeits" },
  { type: "paragraph", text: "GLP-1 medications purchased outside licensed pharmacies — through websites, social media, or 'wellness' channels — carry documented risks of counterfeit, contaminated, or mislabeled product. The FDA has issued repeated warnings about compounded and counterfeit GLP-1 products. Legitimate prescriptions come from a licensed clinician working with a licensed pharmacy, and that pathway exists precisely because these medications require medical oversight." },
  { type: "callout", tone: "warning", text: "Novalyte AI does not prescribe, dispense, or sell GLP-1 medications. The platform connects patients with verified clinics; any prescription is made by a licensed clinician within the patient's clinical relationship." },

  { type: "heading", level: 2, id: "a-realistic-picture", text: "A realistic picture" },
  { type: "paragraph", text: "GLP-1 medications have meaningfully expanded the toolkit for chronic weight management in eligible patients. They are not, however, a substitute for sustained behavioral change, ongoing monitoring, or addressing the root lifestyle and metabolic drivers of weight. The strongest outcomes tend to come from coordinated care: a prescribing clinician, structured lifestyle support, and a clear plan for what happens after the medication ends." },
];

// ────────────────────────────────────────────────────────────────────────────
// Article 3: State of men's health clinic operations — 1,200+ words
// ────────────────────────────────────────────────────────────────────────────
const opsBlocks: ArticleBlock[] = [
  { type: "paragraph", text: "Men's health clinics have grown rapidly over the past several years, driven by demand for TRT, medical weight loss, hair restoration, sexual wellness, and longevity-focused care. But the operational reality behind that growth is more fragmented than the patient experience suggests. This article outlines where fragmentation creates cost, what connected infrastructure changes, and why operational maturity — not treatment menu — increasingly separates clinics that scale from those that stall." },

  { type: "callout", tone: "info", text: "Direct answer: most men's health clinics operate across disconnected point tools — marketing, intake, EHR, lab ordering, telehealth, billing, staffing, and equipment sourcing. Each tool solves a local problem; together they create friction, duplicate work, and make scaling expensive. Connected infrastructure coordinates these layers without replacing the clinic's clinical judgment." },

  { type: "heading", level: 2, id: "where-clinic-operations-fragment", text: "Where clinic operations fragment" },
  { type: "paragraph", text: "A typical independent men's health clinic runs on a stack that grew organically: a marketing platform for paid acquisition, a separate form builder for intake, an EHR configured for a different specialty, a third-party lab portal, a telehealth tool, a billing service, and an equipment supplier they found through referral. Each connection point was solved at the moment it became urgent." },
  { type: "paragraph", text: "The hidden costs of that stack show up in places operators feel but rarely quantify: hours spent reconciling leads that never made it into the EHR, intake forms that capture data the EHR then asks for again, lab orders that travel by email, no-shows that no one followed up with, vendor inquiries that sit in a shared inbox, and clinical staff performing administrative work that scales linearly with patient volume." },
  { type: "table", headers: ["Operational layer", "Common point tool", "Typical friction"], rows: [
    ["Patient acquisition", "Paid ads + landing pages", "Leads arrive without structured data; conversion hard to attribute."],
    ["Intake & assessment", "PDF forms, generic form builders", "Manual re-entry into EHR; incomplete or duplicate data."],
    ["EHR & clinical workflow", "Specialty-mismatched EHR", "Customization debt; clinician clicks instead of configured templates."],
    ["Lab ordering", "Email/fax to reference lab", "Results may not auto-flow back into the chart."],
    ["Telehealth", "Standalone video platform", "No connection to scheduling, billing, or chart."],
    ["Billing & revenue cycle", "Outsourced biller, monthly reports", "Limited visibility into denial causes or claim status."],
    ["Workforce", "General healthcare job boards", "Candidates without men's-health-specific experience."],
    ["Equipment & supplies", "Piecemeal vendor relationships", "Reordering is manual; pricing not benchmarked."],
  ]},

  { type: "heading", level: 2, id: "what-connected-infrastructure-changes", text: "What connected infrastructure changes" },
  { type: "paragraph", text: "Connected infrastructure does not mean a single monolithic platform owned by one vendor. It means the operational layers above exchange structured data, surface cross-layer insight, and reduce the manual coordination that drains clinical and administrative time. The right test of 'connected' is whether a single patient journey — from inquiry, to consult, to lab, to prescription, to follow-up — moves without re-keying." },
  { type: "list", items: [
    "Structured intake that flows into the EHR — eliminating duplicate data entry and improving data quality.",
    "Lab ordering and results integration — so clinical decisions are not gated on a nurse checking email.",
    "Telehealth that connects to scheduling, billing, and chart — so the visit is a real encounter, not a video call.",
    "Workforce marketplaces that surface candidates by licensure, state, and men's-health specialty.",
    "Vendor marketplaces with transparent pricing and verification — so sourcing is not a recurring research project.",
    "Cross-layer analytics — so leadership sees where patients drop out of the funnel, not just where they entered.",
  ]},

  { type: "heading", level: 2, id: "growth-challenges-and-operational-maturity", text: "Growth challenges and operational maturity" },
  { type: "paragraph", text: "Clinic growth in this category typically stalls at specific inflection points. The first is the transition from founder-led operations to delegated operations — when the physician-founder can no longer personally oversee every consult, lead, and vendor relationship. The second is multi-location expansion, where the operational patterns that worked at one site have to be reproducible. The third is telehealth across state lines, where licensure, medical direction, and compliance add structural complexity." },
  { type: "paragraph", text: "Operational maturity — the ability to scale without linearly scaling clinical staff time — depends on whether these inflection points have been anticipated or are encountered reactively. Clinics that scale tend to invest early in connected infrastructure, defined workflows, and the kind of workforce planning that lets them grow into new geographies." },
  { type: "callout", tone: "tip", text: "Tip: A useful diagnostic — ask how long it takes a new patient to move from first inquiry to first scheduled consult, and how many tools are touched along the way. The number of tools and the elapsed time together reveal where the operational debt actually is." },

  { type: "heading", level: 2, id: "where-novalyte-ai-fits", text: "Where Novalyte AI fits" },
  { type: "paragraph", text: "Novalyte AI is positioned as the connective layer — not a replacement for the EHR, the lab, or the biller, but a platform that coordinates patient acquisition, verified clinic discovery, specialized workforce, and B2B sourcing. The aim is to reduce the operational drag that limits clinic growth while preserving clinical autonomy and the existing tools a clinic has invested in." },
  { type: "paragraph", text: "This article reflects Novalyte AI's perspective on the operational state of the men's health category and is not clinical advice. Specific operational decisions — including choice of EHR, billing model, and staffing structure — are made by individual clinics and may warrant specialist operational or legal counsel." },
];

// ────────────────────────────────────────────────────────────────────────────
// Article 4: Recruiting specialized talent — 1,200+ words
// ────────────────────────────────────────────────────────────────────────────
const recruitingBlocks: ArticleBlock[] = [
  { type: "paragraph", text: "Hiring for a men's health clinic is harder than general healthcare hiring suggests. The clinical scope spans TRT, medical weight loss, sexual wellness, hair restoration, peptide therapy, and longevity medicine — and each requires specific licensure, comfort with the patient conversations these treatments involve, and operational familiarity with the workflows that support them. This article explains why hiring is structurally difficult, what roles are most often needed, and what matching factors actually predict fit." },

  { type: "callout", tone: "info", text: "Direct answer: men's health hiring is hard because the candidate pool is small (specialty-specific experience is uncommon), licensure matters (especially for telehealth across state lines), and general healthcare job boards surface candidates without the specialty context. Specialized matching on licensure, state, and men's-health specialty materially improves fit." },

  { type: "heading", level: 2, id: "why-hiring-is-hard", text: "Why hiring is hard" },
  { type: "paragraph", text: "General healthcare job boards are optimized for volume — they surface candidates broadly, but the filters that matter for men's health (state-by-state licensure, specialty experience, comfort with telehealth delivery, and willingness to discuss sexual wellness or weight management) are usually absent or shallow. The result is a high volume of applications, most of which fail at licensure or specialty fit — and the operational cost of filtering that volume falls on the clinic." },
  { type: "paragraph", text: "The mismatch is structural: the men's health candidate pool is small relative to demand, the work spans clinical and operational roles, and the regulatory complexity (especially telehealth) means the wrong hire creates real compliance exposure, not just operational drag." },
  { type: "table", headers: ["Hiring challenge", "Why it happens", "Operational consequence"], rows: [
    ["Licensure mismatch", "Boards surface candidates not licensed in the clinic's state(s)", "Time wasted on candidates who cannot legally practice"],
    ["No specialty experience", "General boards don't filter for TRT/GLP-1/sexual wellness experience", "Longer ramp-up; protocol deviations"],
    ["Telehealth comfort varies", "Not every licensed clinician is comfortable delivering care remotely", "Scheduling gaps; uneven patient experience"],
    ["Medical director scarcity", "State-specific requirements and liability concerns limit supply", "Compliance bottlenecks for telehealth expansion"],
    ["Operational roles underspecified", "Coordinator/RCM roles blur across clinics", "Mis-hires that don't survive onboarding"],
  ]},

  { type: "heading", level: 2, id: "roles-men-health-clinics-need", text: "Roles men's health clinics need" },
  { type: "paragraph", text: "A mature men's health clinic typically requires a mix of clinical, mid-level, support, and operational roles. The exact mix depends on the treatment menu, telehealth footprint, and patient volume." },
  { type: "list", items: [
    "Physicians — oversight of clinical protocols, complex case management, and (for telehealth) medical direction.",
    "Nurse practitioners and physician assistants — primary consult delivery, follow-ups, prescription management within scope.",
    "Registered nurses — clinical support, injection administration, patient education, lab coordination.",
    "Medical assistants — rooming, vitals, intake support, chart preparation.",
    "Phlebotomists — on-site blood draws for hormone and metabolic panels.",
    "Medical directors — supervisory structure for telehealth and protocol governance, where required.",
    "Patient coordinators — inquiry-to-consult conversion, scheduling, follow-up.",
    "Revenue cycle specialists — claims, denials, patient billing, payer relationships.",
    "Compliance specialists — licensure tracking, HIPAA, telehealth regulatory adherence.",
    "Clinic administrators — overall operations, vendor relationships, growth planning.",
  ]},

  { type: "heading", level: 2, id: "matching-factors-that-predict-fit", text: "Matching factors that predict fit" },
  { type: "paragraph", text: "Fit is more than credentials. The matching factors that actually predict whether a hire succeeds in a men's health clinic combine licensure, location, specialty exposure, and operational preferences." },
  { type: "list", ordered: true, items: [
    "Licensure — current, unrestricted license in the state(s) the clinic operates in.",
    "Licensed states — for telehealth, the set of states the clinician is licensed in defines the patient population they can serve.",
    "Specialty exposure — experience with TRT, GLP-1, sexual wellness, longevity, or peptide protocols as relevant to the role.",
    "Remote availability — willingness and ability to deliver care via telehealth.",
    "Employment preference — W-2 vs 1099 vs locum; mismatches here create early attrition.",
    "Experience level — appropriate to the role (e.g., medical director typically requires seasoned licensure).",
    "Schedule alignment — clinics with extended hours need clinicians who can staff them.",
    "Credential status — verified credentials reduce onboarding risk.",
  ]},
  { type: "callout", tone: "tip", text: "Tip: A short screening conversation focused on licensure, telehealth comfort, and patient-conversation comfort (e.g., discussing sexual wellness or weight) saves hours of interview time downstream. These factors filter more reliably than resume keywords." },

  { type: "heading", level: 2, id: "clinic-responsibilities-remain-with-the-clinic", text: "Clinic responsibilities remain with the clinic" },
  { type: "paragraph", text: "Platforms like Novalyte AI can surface candidates and coordinate applications, but they do not perform hiring. Background checks, credential verification, reference checks, employment agreements, and onboarding remain the clinic's responsibility. This separation matters: a marketplace improves match quality, but the clinic remains the employer and the bearer of compliance and clinical-governance obligations." },
  { type: "paragraph", text: "This article is operational guidance from Novalyte AI's perspective on the men's health workforce; it is not legal or HR advice. Clinics should consult qualified employment counsel and HR specialists for jurisdiction-specific hiring practices." },
];

// ────────────────────────────────────────────────────────────────────────────
// Article 5: Longevity medicine — 1,500+ words
// ────────────────────────────────────────────────────────────────────────────
const longevityBlocks: ArticleBlock[] = [
  { type: "paragraph", text: "Longevity medicine has moved from a fringe interest to a recognizable category within men's health. But the field sits at an awkward intersection of legitimate preventive care, advanced diagnostics, and aggressive marketing. This article explains what longevity medicine actually includes today, where evidence is strong versus speculative, and how to evaluate claims critically — without dismissing the underlying goal of extending the healthy portion of life." },

  { type: "callout", tone: "info", text: "Direct answer: longevity medicine is a real but emerging field. Its strongest elements overlap with established preventive medicine (exercise, sleep, nutrition, metabolic health, early detection). Its weaker elements include unvalidated biomarker panels, unproven interventions marketed aggressively, and overpromising on lifespan. The right approach is to anchor on what is well-evidenced and to apply strict scrutiny to anything sold as breakthrough." },

  { type: "heading", level: 2, id: "what-longevity-medicine-includes", text: "What longevity medicine includes" },
  { type: "paragraph", text: "There is no single agreed definition, but the field generally spans four overlapping layers:" },
  { type: "list", ordered: true, items: [
    "Preventive and lifestyle medicine — exercise, sleep, nutrition, stress management, smoking cessation, alcohol moderation. These are the foundation of any legitimate longevity approach and have the strongest evidence base.",
    "Metabolic and hormonal optimization — management of insulin resistance, lipid disorders, blood pressure, thyroid function, and (where clinically indicated) testosterone.",
    "Advanced diagnostics — body composition analysis, continuous glucose monitoring, advanced lipid testing, VO2 max measurement, and certain biomarker panels. Their value depends on whether results change clinical action.",
    "Interventions with varying evidence — from metformin in non-diabetics to NAD+ precursors, peptides, and plasma-related protocols. The evidence base for these in humans is heterogeneous and often preliminary.",
  ]},
  { type: "paragraph", text: "The strongest longevity programs look a lot like excellent preventive medicine with added diagnostic depth. The weakest ones lean heavily on supplements, proprietary panels, and experimental interventions with thin human evidence." },

  { type: "heading", level: 2, id: "evidence-vs-claims", text: "Evidence vs claims: a comparison" },
  { type: "table", headers: ["Intervention area", "Evidence status (general)", "Reasonable framing"], rows: [
    ["Regular exercise (aerobic + resistance)", "Strong, consistent across populations", "Core foundation; non-negotiable."],
    ["Sleep optimization", "Strong; sleep duration and quality predict multiple outcomes", "Foundation; address disorders like apnea."],
    ["Nutrition patterns (Mediterranean-style)", "Strong for cardiometabolic outcomes", "Foundation; sustained patterns matter more than any single food."],
    ["Smoking cessation", "Among the highest-impact interventions", "Foundation; non-negotiable."],
    ["Blood pressure, lipid, glucose management", "Strong when clinically indicated", "Treat per guidelines; not optional."],
    ["Testosterone replacement (when deficient)", "Strong for confirmed deficiency; not for 'optimization' in normal men", "Clinical therapy, not longevity shortcut."],
    ["Continuous glucose monitoring in non-diabetics", "Emerging; behavior change tool, not diagnostic standard", "Optional; meaningful for some, not a standard of care."],
    ["Metformin in non-diabetics", "Mixed; some observational signal, RCT evidence limited", "Investigational; not standard longevity care."],
    ["NAD+ precursors (NR, NMN)", "Limited human outcome data; mostly biomarker studies", "Investigational; be cautious with marketing claims."],
    ["Peptide therapies (most categories)", "Heterogeneous; many lack robust human trials", "Use only in legitimate clinical context; beware unsupported claims."],
    ["Plasma / transfusion-based protocols", "Not supported by human longevity evidence", "Avoid outside clinical trials; safety concerns."],
  ]},
  { type: "callout", tone: "warning", text: "Warning: Interventions marketed as 'anti-aging breakthroughs' — particularly those sold direct-to-consumer without a clinical relationship — should be treated with high skepticism. The FDA has taken action against clinics making unsupported claims, and several categories (notably certain peptides) have faced regulatory restrictions. A real clinical relationship, lab-guided decisions, and monitored outcomes are not optional accessories; they are the practice of medicine." },

  { type: "heading", level: 2, id: "biomarkers-when-they-help-and-when-they-dont", text: "Biomarkers: when they help and when they don't" },
  { type: "paragraph", text: "A core promise of longevity medicine is 'measure more, intervene earlier.' This is sound in principle — many conditions (hypertension, dyslipidemia, insulin resistance, low testosterone) are silent for years. But not every biomarker is actionable. The useful question is not 'can it be measured?' but 'will the result change what I do?'" },
  { type: "list", items: [
    "Actionable biomarkers — blood pressure, fasting glucose/HbA1c, lipid panel, TSH, morning testosterone (when indicated), CBC, basic metabolic panel, vitamin D in some populations.",
    "Situational biomarkers — apolipoprotein B, Lp(a), high-sensitivity CRP, fasting insulin, body composition, VO2 max. Useful in specific contexts; not always necessary.",
    "Low-actionability biomarkers — 'biological age' clocks (epigenetic clocks) vary across assays and tissues; their clinical utility for individual decisions is not established.",
  ]},
  { type: "paragraph", text: "The risk of over-testing is not just cost — it is the cascade of borderline results that lead to further testing, anxiety, and interventions of uncertain benefit. Good clinicians are selective about what they measure, and explain why each test matters." },

  { type: "heading", level: 2, id: "how-to-evaluate-a-longevity-program", text: "How to evaluate a longevity program" },
  { type: "list", items: [
    "Does it start with the foundations — exercise, sleep, nutrition, smoking cessation, alcohol moderation — rather than jumping to interventions?",
    "Does a licensed clinician review labs and symptoms before recommending anything?",
    "Are interventions recommended only when there is a clinical indication, not as 'optimization' for its own sake?",
    "Is there a plan for monitoring outcomes, not just starting interventions?",
    "Are claims about lifespan or 'reversing aging' avoided, and are limitations acknowledged?",
    "Are experimental interventions clearly identified as such, with informed consent and not aggressive marketing?",
    "Is cost transparent — including the cost of ongoing monitoring and follow-up?",
  ]},

  { type: "heading", level: 2, id: "the-honest-picture", text: "The honest picture" },
  { type: "paragraph", text: "Longevity medicine's strongest contribution is bringing preventive intensity to people who otherwise fall through the cracks of standard primary care. Periodic deep labs, structured lifestyle plans, and a clinician who tracks metrics over time can genuinely improve healthspan. The category's weakest contribution is the marketing layer that wraps the same interventions in 'breakthrough' framing and sells them at premium prices to people who would benefit more from consistent basics." },
  { type: "paragraph", text: "For most men, the highest-return longevity investment is behavioral and free or low-cost: consistent exercise, adequate sleep, sustained nutrition patterns, and management of modifiable cardiometabolic risk. Everything else is incremental, clinical, and individualized." },
  { type: "callout", tone: "tip", text: "Tip: If a longevity program's first recommendation is a supplement or experimental intervention rather than structured behavioral change, ask why. The hierarchy of evidence consistently puts behavior first." },

  { type: "heading", level: 2, id: "disclaimer", text: "Disclaimer" },
  { type: "paragraph", text: "This article is educational. Novalyte AI does not endorse specific longevity protocols, prescribe interventions, or sell supplements. Decisions about diagnostics, supplementation, and treatment should be made with a licensed clinician in the context of an individual clinical relationship." },
];

// ────────────────────────────────────────────────────────────────────────────
// Article 6: Compliant telehealth men's health practice — 1,200+ words
// ────────────────────────────────────────────────────────────────────────────
const telehealthBlocks: ArticleBlock[] = [
  { type: "paragraph", text: "Delivering men's health care through telehealth — TRT, medical weight loss, sexual wellness, hormone optimization — introduces specific operational and regulatory obligations that do not apply to a single-state in-person clinic. This article outlines the structural considerations clinics should weigh when building or expanding a telehealth men's health practice. It is operational guidance, not legal advice." },

  { type: "callout", tone: "info", text: "Direct answer: a compliant multi-state telehealth men's health practice requires (1) clinician licensure in each state of patient residence, (2) an appropriate medical direction / supervisory structure, (3) documented clinical workflows that meet the standard of care, and (4) attention to prescribing rules — particularly for controlled substances. Telehealth does not relax clinical standards; it adds a regulatory layer to them." },

  { type: "heading", level: 2, id: "licensure-across-state-lines", text: "Licensure across state lines" },
  { type: "paragraph", text: "In the United States, healthcare licensure is state-based. A clinician must generally be licensed in the state where the patient is located at the time of the encounter — not merely where the clinic is headquartered. This means a telehealth practice serving patients in 10 states needs clinicians licensed in all 10, plus systems to verify patient location at the time of every visit." },
  { type: "list", items: [
    "State-by-state licensure — the default requirement; per-state application, fees, and renewal.",
    "Interstate licensure compacts — the Interstate Medical Licensure Compact (IMLC) for physicians and the APRN Compact for nurse practitioners streamline application but do not create a single license; clinicians still hold individual state licenses.",
    "Patient location verification — documented at every encounter, not just at intake; relevant for travel and relocation.",
    "Licensure tracking — operational system to monitor expiration, restrictions, and disciplinary actions per state.",
  ]},
  { type: "callout", tone: "warning", text: "Telehealth rules continue to evolve. Some state-level flexibilities introduced during public health emergencies have ended or been modified. Clinics must verify the current requirements in each state of operation; outdated assumptions create real compliance exposure." },

  { type: "heading", level: 2, id: "medical-direction-and-supervision", text: "Medical direction and supervision" },
  { type: "paragraph", text: "Telehealth men's health clinics that operate with nurse practitioners or physician assistants typically require a medical director or supervising physician relationship, the specifics of which vary by state. Some states require collaborative practice agreements; others require varying degrees of chart review or co-signature; some require on-site supervision that telehealth models cannot satisfy without structural adaptation." },
  { type: "paragraph", text: "Medical direction is not a nominal role. A medical director is responsible for clinical protocols, formulary decisions, quality assurance, and — where required — supervisory oversight. A clinic that treats the medical director role as a paperwork exercise is operating outside the spirit of the requirements and creating liability exposure." },
  { type: "table", headers: ["Element", "What it typically involves", "Common pitfalls"], rows: [
    ["Collaborative/supervisory agreement", "Documented scope of practice and review cadence", "Agreements that exist on paper but are not followed"],
    ["Protocol governance", "Clinical protocols for prescribing, monitoring, escalation", "Protocols not updated as evidence or regulations change"],
    ["Chart review / co-signature", "Where required, sampled or full chart review", "Co-signatures without meaningful review"],
    ["Quality assurance", "Adverse event tracking, audits, patient safety reporting", "No structured QA process"],
    ["Formulary oversight", "What is prescribed, at what dose, with what monitoring", "Open-ended formularies without governance"],
  ]},

  { type: "heading", level: 2, id: "clinical-workflows-and-standard-of-care", text: "Clinical workflows and standard of care" },
  { type: "paragraph", text: "Telehealth does not lower the standard of care; it requires clinics to document how they meet it. For men's health, that typically means structured intake, laboratory confirmation before prescribing (notably for TRT), clear follow-up cadence, and protocols for handling abnormal results or red-flag symptoms. A patient who receives a prescription after a 5-minute video visit and no labs is not receiving guideline-consistent care, regardless of the modality." },
  { type: "list", items: [
    "Structured intake — full medical history, medication review, contraindication screening.",
    "Laboratory confirmation — for hormone therapy, repeated morning testosterone; for weight management, screening appropriate to the medication considered.",
    "Informed consent — including disclosure of risks, alternatives, and the off-label status of any medication used outside its primary indication.",
    "Follow-up cadence — documented plan for labs, symptom review, and dose adjustment.",
    "Red-flag protocols — clear pathways for symptoms requiring in-person evaluation (chest pain, severe headache, urinary obstruction, signs of pancreatitis).",
    "Continuity of care — documentation that allows another clinician to assume care seamlessly.",
  ]},

  { type: "heading", level: 2, id: "prescribing-considerations", text: "Prescribing considerations" },
  { type: "paragraph", text: "Prescribing through telehealth introduces specific constraints. Testosterone is a controlled substance (Schedule III) in the United States, and federal rules — including the Ryan Haight Act — govern controlled-substance prescribing via telehealth. Recent federal telehealth flexibilities for controlled substances have been extended through transitional periods but have specific expiration and rulemaking timelines; clinics must monitor current federal and state rules." },
  { type: "paragraph", text: "GLP-1 medications are generally not controlled substances, but their prescription still requires clinical indication, monitoring, and attention to sourcing (only licensed pharmacies; the FDA has warned against compounded or counterfeit GLP-1 products). For both categories, prescribing decisions are clinical — made by a licensed clinician within an established patient relationship — and not platform decisions." },

  { type: "heading", level: 2, id: "operational-and-privacy-considerations", text: "Operational and privacy considerations" },
  { type: "list", items: [
    "HIPAA-compliant video platform — Business Associate Agreement in place; not consumer video tools.",
    "EHR integration — telehealth visits documented as real encounters, not ephemeral calls.",
    "Patient identity verification — preventing prescription fraud and ensuring the right patient receives care.",
    "State-specific consent — some states require specific informed consent for telehealth; some require patient acknowledgment of the modality's limitations.",
    "Records retention — per state requirements, including the patient's state of residence at the time of care.",
    "Insurance and malpractice — coverage that explicitly includes telehealth across the states of operation.",
  ]},

  { type: "callout", tone: "tip", text: "Tip: Build a per-state compliance matrix that tracks licensure requirements, supervisory rules, telehealth consent requirements, and prescribing rules for every state you operate in. Reviewing this matrix quarterly is far cheaper than responding to a compliance inquiry after the fact." },

  { type: "heading", level: 2, id: "where-novalyte-ai-fits", text: "Where Novalyte AI fits" },
  { type: "paragraph", text: "Novalyte AI is a technology platform. It does not provide legal counsel, medical direction, or licensure. It connects clinics with verified workforce, structured intake tooling, and operational coordination — but the regulatory responsibilities described here remain with the clinic, its clinicians, and its counsel. Telehealth compliance is not solved by software; it is supported by software, but it is fundamentally a clinical, legal, and operational discipline owned by the practice." },
  { type: "paragraph", text: "This article is operational guidance, not legal advice. Clinics should engage qualified healthcare counsel and compliance specialists to verify requirements for their specific footprint." },
];

// ────────────────────────────────────────────────────────────────────────────
// Assemble articles
// ────────────────────────────────────────────────────────────────────────────

const trtArticle: ArticleContent = {
  slug: "understanding-trt-overview",
  title: "Testosterone Replacement Therapy: A Complete Guide for Men",
  excerpt:
    "An educational overview of how testosterone replacement therapy is evaluated, what treatment involves, the monitoring that should accompany it, and the questions worth asking a licensed provider.",
  category: "Testosterone",
  tags: ["TRT", "hypogonadism", "hormone health", "men's health"],
  author: {
    name: "Novalyte Editorial Team",
    role: "Healthcare Content Editors",
    bio:
      "The Novalyte Editorial Team researches and writes educational content on men's health treatments, clinic operations, and the broader healthcare ecosystem. Editorial content is reviewed against public-health and professional-society guidance before publication.",
  },
  medicalReviewer: {
    name: "Novalyte Medical Review Panel",
    role: "Clinical Review (Educational)",
  },
  publishedAt: "2026-06-15T09:00:00.000Z",
  updatedAt: "2026-06-20T09:00:00.000Z",
  readingTime: 9,
  heroImage: "/images/articles/trt-consultation.jpg",
  heroImageAlt:
    "A male patient reviewing lab results with a healthcare provider during a testosterone evaluation consult.",
  tableOfContents: tocFromBlocks(trtBlocks),
  body: trtBlocks,
  references: [
    { label: "Endocrine Society — Clinical Practice Guidelines on Testosterone Therapy in Adult Men", source: "Endocrine Society (for general reference)" },
    { label: "American Urological Association — Evaluation and Management of Testosterone Deficiency Guidelines", source: "American Urological Association (for general reference)" },
    { label: "U.S. FDA — Testosterone and Other Anabolic Androgenic Steroids safety communications", source: "U.S. FDA (for general reference)" },
    { label: "NIH/NIDDK — Patient education on testosterone and men's health", source: "National Institute of Diabetes and Digestive and Kidney Diseases (for general reference)" },
  ],
  faqs: [
    {
      question: "Can I start TRT based on a single low testosterone lab result?",
      answer:
        "No. Guideline-consistent evaluation requires at least two separate morning testosterone measurements confirming low levels, alongside symptom assessment and exclusion of reversible causes. A single result is not a basis for diagnosis or prescription.",
    },
    {
      question: "Will TRT make me more athletic or build muscle even if my levels are normal?",
      answer:
        "TRT is prescribed only for confirmed low testosterone. Using testosterone to enhance performance in men with normal levels is misuse, not therapy, and carries documented risks including infertility, cardiovascular strain, and suppression of natural hormone production.",
    },
    {
      question: "Does TRT affect fertility?",
      answer:
        "Yes. TRT suppresses sperm production and can cause infertility, which may persist after discontinuation. Men planning to father children should discuss fertility-preserving alternatives (such as hCG) with their clinician before starting.",
    },
    {
      question: "How often are labs monitored during TRT?",
      answer:
        "Typically at 3 to 6 months initially, then at regular intervals once stable. Monitoring generally includes total testosterone (timed to the dosing schedule), hematocrit, and age-appropriate prostate screening, among other labs as clinically indicated.",
    },
    {
      question: "Can Novalyte AI prescribe TRT?",
      answer:
        "No. Novalyte AI is a technology platform that connects patients with verified clinics. Prescriptions are issued by licensed clinicians within an individual clinical relationship, not by the platform itself.",
    },
  ],
  relatedTreatment: "Testosterone Replacement Therapy",
};

const glp1Article: ArticleContent = {
  slug: "glp-1-medical-weight-loss",
  title: "GLP-1 Medications and Medical Weight Loss: What Men Should Know",
  excerpt:
    "An educational look at how GLP-1 medications work, who tends to be evaluated for them, what monitoring is involved, and how they fit alongside nutrition, activity, and behavioral support.",
  category: "Weight Management",
  tags: ["GLP-1", "medical weight loss", "obesity", "metabolic health"],
  author: {
    name: "Novalyte Editorial Team",
    role: "Healthcare Content Editors",
    bio:
      "The Novalyte Editorial Team researches and writes educational content on men's health treatments, clinic operations, and the broader healthcare ecosystem. Editorial content is reviewed against public-health and professional-society guidance before publication.",
  },
  medicalReviewer: {
    name: "Novalyte Medical Review Panel",
    role: "Clinical Review (Educational)",
  },
  publishedAt: "2026-06-29T09:00:00.000Z",
  updatedAt: "2026-06-29T09:00:00.000Z",
  readingTime: 9,
  heroImage: "/images/articles/glp1-consultation.jpg",
  heroImageAlt:
    "A clinician reviewing a medical weight loss plan with a male patient, including nutrition and activity tracking.",
  tableOfContents: tocFromBlocks(glp1Blocks),
  body: glp1Blocks,
  references: [
    { label: "U.S. FDA — GLP-1 receptor agonist safety communications and prescribing information", source: "U.S. FDA (for general reference)" },
    { label: "American Gastroenterological Association — Clinical Practice Guideline on Pharmacologic Interventions for Obesity", source: "American Gastroenterological Association (for general reference)" },
    { label: "CDC — Adult obesity facts and weight management resources", source: "U.S. Centers for Disease Control and Prevention (for general reference)" },
    { label: "NIH/NIDDK — Weight-management and obesity research education", source: "National Institute of Diabetes and Digestive and Kidney Diseases (for general reference)" },
  ],
  faqs: [
    {
      question: "Are GLP-1 medications a 'quick fix' for weight loss?",
      answer:
        "No. GLP-1 medications are adjuncts to lifestyle intervention. They modify appetite and satiety signaling, which can support behavior change, but weight regain after discontinuation is well documented when nutrition and activity patterns are not sustained.",
    },
    {
      question: "Can I get a GLP-1 prescription online from any website?",
      answer:
        "Legitimate prescriptions come from a licensed clinician working with a licensed pharmacy, following a clinical evaluation. Products purchased through unverified websites, social media, or 'wellness' channels carry documented risks of counterfeit or contaminated product, and the FDA has issued repeated warnings about these sources.",
    },
    {
      question: "What are the most common side effects of GLP-1 medications?",
      answer:
        "Gastrointestinal effects — nausea, reflux, constipation, diarrhea, and reduced appetite — are most common, particularly early in treatment or after dose increases. Titration schedules are designed to balance efficacy with tolerability.",
    },
    {
      question: "Who should not take GLP-1 medications?",
      answer:
        "People with a personal or family history of medullary thyroid carcinoma or MEN2, prior pancreatitis, severe gastroparesis, or who are pregnant or breastfeeding are among those for whom GLP-1 therapy is typically contraindicated or requires careful clinical judgment. A full history is essential.",
    },
    {
      question: "Does Novalyte AI prescribe GLP-1 medications?",
      answer:
        "No. Novalyte AI is a technology platform connecting patients with verified clinics. Any prescription is made by a licensed clinician within the patient's clinical relationship.",
    },
  ],
  relatedTreatment: "Medical Weight Loss",
};

const opsArticle: ArticleContent = {
  slug: "state-of-mens-health-clinic-operations",
  title: "The State of Men's Health Clinic Operations",
  excerpt:
    "Why fragmented systems limit clinic growth, what connected infrastructure actually changes, and where operational maturity — not treatment menu — separates clinics that scale from those that stall.",
  category: "Clinic Operations",
  tags: ["operations", "growth", "infrastructure", "scaling"],
  author: {
    name: "Novalyte Strategy Team",
    role: "Healthcare Operations Analysts",
    bio:
      "The Novalyte Strategy Team analyzes operational patterns across the men's health category — clinic economics, workforce, infrastructure, and the structural factors that shape how clinics grow.",
  },
  medicalReviewer: null,
  publishedAt: "2026-07-08T09:00:00.000Z",
  updatedAt: "2026-07-08T09:00:00.000Z",
  readingTime: 8,
  heroImage: "/images/articles/clinic-operations.jpg",
  heroImageAlt:
    "Clinical and operations team reviewing a clinic intake workflow together.",
  tableOfContents: tocFromBlocks(opsBlocks),
  body: opsBlocks,
  references: [
    { label: "U.S. HHS — Health IT and connected-care operational resources", source: "U.S. Department of Health and Human Services (for general reference)" },
    { label: "Healthcare operational maturity frameworks — industry reference", source: "Industry operational frameworks (for general reference)" },
    { label: "Novalyte AI — operational category overview", source: "Novalyte AI editorial (for general reference)" },
  ],
  faqs: [
    {
      question: "Does connected infrastructure mean replacing our EHR?",
      answer:
        "Not necessarily. Connected infrastructure refers to layers exchanging structured data and reducing manual coordination. Many clinics keep their existing EHR while adding coordination layers for intake, workforce, sourcing, and analytics.",
    },
    {
      question: "Where do clinics typically see the biggest operational drag?",
      answer:
        "Most often at the boundaries between tools — leads that do not enter the EHR, lab results that travel by email, telehealth visits that are not real chart encounters, and vendor inquiries that sit in shared inboxes. Each boundary creates re-keying and lost signal.",
    },
    {
      question: "Is this article clinical advice?",
      answer:
        "No. It is an operational perspective from Novalyte AI on the men's health category. Specific operational decisions — including EHR, billing, and staffing structure — are made by individual clinics and may warrant specialist operational or legal counsel.",
    },
  ],
  relatedTreatment: null,
};

const recruitingArticle: ArticleContent = {
  slug: "recruiting-specialized-talent-mens-health",
  title: "Recruiting Specialized Talent for Men's Health Clinics",
  excerpt:
    "Why hiring nurse practitioners, medical directors, and coordinators for men's health is structurally difficult, what roles are most often needed, and what matching factors actually predict fit.",
  category: "Workforce",
  tags: ["hiring", "workforce", "medical director", "telehealth"],
  author: {
    name: "Novalyte Workforce Team",
    role: "Healthcare Workforce Analysts",
    bio:
      "The Novalyte Workforce Team studies patterns in men's health hiring — licensure, specialty matching, telehealth delivery, and the operational factors that determine whether a hire succeeds in a men's health clinic.",
  },
  medicalReviewer: null,
  publishedAt: "2026-07-11T09:00:00.000Z",
  updatedAt: "2026-07-11T09:00:00.000Z",
  readingTime: 8,
  heroImage: "/images/articles/workforce-recruiting.jpg",
  heroImageAlt:
    "A clinic administrator interviewing a nurse practitioner candidate for a men's health role.",
  tableOfContents: tocFromBlocks(recruitingBlocks),
  body: recruitingBlocks,
  references: [
    { label: "U.S. Bureau of Labor Statistics — Healthcare Occupations outlook", source: "U.S. BLS (for general reference)" },
    { label: "Federation of State Medical Boards — Licensure and compacts overview", source: "Federation of State Medical Boards (for general reference)" },
    { label: "American Association of Nurse Practitioners — Practice authority by state", source: "AANP (for general reference)" },
  ],
  faqs: [
    {
      question: "Why doesn't a general healthcare job board work for men's health roles?",
      answer:
        "General boards optimize for volume but lack filters for the factors that matter most in men's health — state-by-state licensure, specialty experience (TRT, GLP-1, sexual wellness), and telehealth comfort. The result is a high volume of applications that fail at the most basic filters.",
    },
    {
      question: "What is a medical director's actual role in a telehealth clinic?",
      answer:
        "A medical director is responsible for clinical protocols, formulary governance, quality assurance, and supervisory oversight where required. The role is not nominal; treating it as paperwork creates real liability exposure.",
    },
    {
      question: "Does Novalyte AI perform background checks or credentialing?",
      answer:
        "No. Novalyte AI surfaces candidates and coordinates applications, but background checks, credential verification, reference checks, employment agreements, and onboarding remain the clinic's responsibility as the employer.",
    },
    {
      question: "What's the most important screening question for men's health candidates?",
      answer:
        "Beyond licensure, comfort with the patient conversations these treatments involve — sexual wellness, weight, hormones — is one of the strongest predictors of fit. Candidates uncomfortable with these conversations rarely succeed regardless of credentials.",
    },
  ],
  relatedTreatment: null,
};

const longevityArticle: ArticleContent = {
  slug: "longevity-medicine-science-vs-hype",
  title: "Longevity Medicine: Separating Science from Hype",
  excerpt:
    "A grounded look at what longevity medicine actually includes today, where the evidence is strong versus speculative, and how to evaluate claims critically without dismissing the underlying goal of extending healthspan.",
  category: "Longevity",
  tags: ["longevity", "healthspan", "preventive medicine", "evidence"],
  author: {
    name: "Novalyte Editorial Team",
    role: "Healthcare Content Editors",
    bio:
      "The Novalyte Editorial Team researches and writes educational content on men's health treatments, clinic operations, and the broader healthcare ecosystem. Editorial content is reviewed against public-health and professional-society guidance before publication.",
  },
  medicalReviewer: {
    name: "Novalyte Medical Review Panel",
    role: "Clinical Review (Educational)",
  },
  publishedAt: "2026-07-14T09:00:00.000Z",
  updatedAt: "2026-07-14T09:00:00.000Z",
  readingTime: 10,
  heroImage: "/images/articles/longevity-consultation.jpg",
  heroImageAlt:
    "A clinician and patient discussing preventive health metrics and lab results during a longevity consultation.",
  tableOfContents: tocFromBlocks(longevityBlocks),
  body: longevityBlocks,
  references: [
    { label: "CDC — Healthy aging and preventive care resources", source: "U.S. Centers for Disease Control and Prevention (for general reference)" },
    { label: "NIH National Institute on Aging — Aging research and healthspan education", source: "National Institute on Aging (for general reference)" },
    { label: "U.S. FDA — Dietary supplements and anti-aging claims enforcement", source: "U.S. FDA (for general reference)" },
    { label: "American College of Preventive Medicine — Lifestyle medicine guidance", source: "American College of Preventive Medicine (for general reference)" },
  ],
  faqs: [
    {
      question: "Is 'biological age' testing reliable?",
      answer:
        "Epigenetic 'biological age' clocks vary across assays and tissues, and their clinical utility for individual decisions is not yet established. They may be interesting research tools, but they are not standard clinical diagnostics and should not drive treatment decisions on their own.",
    },
    {
      question: "Are peptides part of legitimate longevity medicine?",
      answer:
        "Some peptides have legitimate clinical uses, but many marketed for 'longevity' lack robust human evidence. The FDA has taken action against certain peptide categories. Any peptide therapy should occur in a legitimate clinical context with informed consent, not through direct-to-consumer channels.",
    },
    {
      question: "What's the highest-impact longevity intervention for most men?",
      answer:
        "Behavioral. Consistent exercise (aerobic plus resistance), adequate sleep, sustained nutrition patterns, smoking cessation, and management of modifiable cardiometabolic risk. These have the strongest evidence base and are typically free or low-cost.",
    },
    {
      question: "Does Novalyte AI endorse specific longevity protocols?",
      answer:
        "No. Novalyte AI does not endorse protocols, prescribe interventions, or sell supplements. Decisions about diagnostics, supplementation, and treatment should be made with a licensed clinician in an individual clinical relationship.",
    },
  ],
  relatedTreatment: "Longevity Medicine",
};

const telehealthArticle: ArticleContent = {
  slug: "compliant-telehealth-mens-health",
  title: "Building a Compliant Telehealth Men's Health Practice",
  excerpt:
    "Operational and structural considerations for delivering men's health care across state lines — licensure, medical direction, clinical workflows, prescribing rules, and privacy obligations.",
  category: "Healthcare Technology",
  tags: ["telehealth", "compliance", "licensure", "medical direction"],
  author: {
    name: "Novalyte Strategy Team",
    role: "Healthcare Operations Analysts",
    bio:
      "The Novalyte Strategy Team analyzes operational patterns across the men's health category — clinic economics, workforce, infrastructure, and the structural factors that shape how clinics grow.",
  },
  medicalReviewer: null,
  publishedAt: "2026-07-15T09:00:00.000Z",
  updatedAt: "2026-07-15T09:00:00.000Z",
  readingTime: 8,
  heroImage: "/images/articles/telehealth-practice.jpg",
  heroImageAlt:
    "A clinician conducting a private telehealth consultation with an adult male patient on a laptop.",
  tableOfContents: tocFromBlocks(telehealthBlocks),
  body: telehealthBlocks,
  references: [
    { label: "U.S. DEA — Ryan Haight Act and telehealth controlled-substance prescribing", source: "U.S. Drug Enforcement Administration (for general reference)" },
    { label: "U.S. HHS — Telehealth policy and compliance resources", source: "U.S. Department of Health and Human Services (for general reference)" },
    { label: "Federation of State Medical Boards — Telehealth licensure and policy", source: "Federation of State Medical Boards (for general reference)" },
    { label: "U.S. FDA — Compounded GLP-1 safety communications", source: "U.S. FDA (for general reference)" },
  ],
  faqs: [
    {
      question: "Does the Interstate Medical Licensure Compact create a single license?",
      answer:
        "No. The IMLC streamlines the application process for physicians, but clinicians still hold individual state licenses and must comply with each state's specific telehealth and prescribing rules.",
    },
    {
      question: "Can testosterone be prescribed via telehealth?",
      answer:
        "Testosterone is a Schedule III controlled substance, and federal rules (including the Ryan Haight Act) govern controlled-substance prescribing via telehealth. Specific flexibilities have transitional timelines; clinics must verify current federal and state rules and ensure an established provider-patient relationship.",
    },
    {
      question: "Whose state licensure matters — the clinic's or the patient's?",
      answer:
        "Generally the patient's. A clinician must typically be licensed in the state where the patient is located at the time of the encounter, which is why telehealth practices need per-state licensure and patient location verification at every visit.",
    },
    {
      question: "Does Novalyte AI provide medical direction or compliance services?",
      answer:
        "No. Novalyte AI is a technology platform. Medical direction, licensure, supervision, and compliance remain the responsibility of the clinic, its clinicians, and qualified healthcare counsel.",
    },
  ],
  relatedTreatment: null,
};

export const ARTICLES: ArticleContent[] = [
  trtArticle,
  glp1Article,
  opsArticle,
  recruitingArticle,
  longevityArticle,
  telehealthArticle,
];

export function getArticleBySlug(slug: string | undefined): ArticleContent | undefined {
  if (!slug) return undefined;
  return ARTICLES.find((a) => a.slug === slug);
}

export function getRelatedArticles(article: ArticleContent, allArticles: ArticleContent[], limit = 3): ArticleContent[] {
  const others = allArticles.filter((a) => a.slug !== article.slug);
  const scored = others.map((a) => {
    let score = 0;
    if (a.category === article.category) score += 3;
    const sharedTags = a.tags.filter((t) => article.tags.includes(t)).length;
    score += sharedTags;
    return { article: a, score };
  });
  const sorted = scored.sort((a, b) => b.score - a.score);
  const matched = sorted.filter((s) => s.score > 0).map((s) => s.article);
  const fillers = sorted.filter((s) => s.score === 0).map((s) => s.article);
  return [...matched, ...fillers].slice(0, limit);
}

export const JOURNAL_CATEGORIES = Array.from(new Set(ARTICLES.map((a) => a.category))).sort();
